Predict your next investment

Venture Capital
lyfecapital.com

See what CB Insights has to offer

Investments

75

Portfolio Exits

10

Funds

4

About LYFE Capital

LYFE Capital operates as a life sciences investment firm. LYFE Capital provides capital to multi-stage companies that are primarily based throughout China and North America. The firm was founded in 2015 and is based in Jingan, Shanghai.

LYFE Capital Headquarter Location

Park Place, 1601 West Nanjing Road Suite 3204-3205

Jingan, Shanghai, 200040,

China

(+86) 21-5220-0390

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest LYFE Capital News

DealShot: 14 Deals Worth $170 Million Involving LYFE Capital, China Structural Reform Fund And More

May 16, 2022

All Rights Reserved. Disclaimer: The views, opinions, forecasts, and statements made by our hosts and guests are the personal views of those respective individuals and may or may not be either endorsed or accepted by China Money Network Limited or the companies with which these individuals are employed. Posting....

LYFE Capital Investments

75 Investments

LYFE Capital has made 75 investments. Their latest investment was in ProfoundBio as part of their Series A - II on June 6, 2022.

CBI Logo

LYFE Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/2/2022

Series A - II

ProfoundBio

$70M

No

6

5/16/2022

Series A - II

Starna Therapeutics

$22.1M

Yes

5

5/9/2022

Series A - II

Bioeast Biotech

$22.7M

Yes

2

5/9/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

4/29/2022

Series A

Subscribe to see more

Subscribe to see more

10

Date

6/2/2022

5/16/2022

5/9/2022

5/9/2022

4/29/2022

Round

Series A - II

Series A - II

Series A - II

Series B

Series A

Company

ProfoundBio

Starna Therapeutics

Bioeast Biotech

Subscribe to see more

Subscribe to see more

Amount

$70M

$22.1M

$22.7M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

6

5

2

10

10

LYFE Capital Portfolio Exits

10 Portfolio Exits

LYFE Capital has 10 portfolio exits. Their latest portfolio exit was Ruike Biotechnology on March 31, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/31/2022

IPO

$99M

Public

1

12/10/2021

IPO

$99M

Public

1

11/15/2021

IPO

$99M

Public

2

8/20/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

7/30/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/31/2022

12/10/2021

11/15/2021

8/20/2021

7/30/2021

Exit

IPO

IPO

IPO

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Public

Public

Subscribe to see more

Subscribe to see more

Sources

1

1

2

10

10

LYFE Capital Fund History

4 Fund Histories

LYFE Capital has 4 funds, including LYFE Capital Fund IV.

Closing Date

Fund

Fund Type

Status

Amount

Sources

4/22/2022

LYFE Capital Fund IV

$935M

1

10/11/2019

LYFE Capital Fund III

$99M

10

5/30/2017

LYFE Capital II

$99M

10

LYFE Capital Fund III (Phoenix)

10

Closing Date

4/22/2022

10/11/2019

5/30/2017

Fund

LYFE Capital Fund IV

LYFE Capital Fund III

LYFE Capital II

LYFE Capital Fund III (Phoenix)

Fund Type

Status

Amount

$935M

$99M

$99M

Sources

1

10

10

10

LYFE Capital Team

7 Team Members

LYFE Capital has 7 team members, including current Founder, Managing Partner, James Zhao.

Name

Work History

Title

Status

James Zhao

Founder, Managing Partner

Current

Roy Xu

Chief Financial Officer

Current

Jack Chen

Managing Partner

Current

William Chen

Managing Director

Current

Yanfei Feng

Managing Director

Current

Name

James Zhao

Roy Xu

Jack Chen

William Chen

Yanfei Feng

Work History

Title

Founder, Managing Partner

Chief Financial Officer

Managing Partner

Managing Director

Managing Director

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.